Jones Financial Companies’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4
Closed -$16 3537
2024
Q3
$16 Hold
4
﹤0.01% 3005
2024
Q2
$9 Buy
+4
New +$10 ﹤0.01% 2416

Jones Financial Companies's LUMO Position: Q4 2024 in Review

Jones Financial Companies sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 4 shares — an estimated $16 sold.

Jones Financial Companies first reported a position in LUMO in Q2 2024 and held it in 2 quarters. The position peaked at $16 in Q3 2024. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

  • Jones Financial Companies reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Jones Financial Companies sold 4 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $16.
  • Jones Financial Companies first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
  • Jones Financial Companies's Lumos Pharma, Inc. Common Stock position peaked at $16 in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on Jones Financial Companies's 13F filing for Q4 2024, filed 6 Feb 2025.